Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation - Fierce Biotech
Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation Fierce Biotech Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines Business Wire Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom Reuters Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion CNBC Pfizer strikes up to $10.5B deal with Chinese biotech Innovent Axios
YesNo saves this item as an on-site live signal so search users can understand how it connects to prediction markets and incubation topics.
If later reporting creates a clear deadline, official source, or verifiable outcome, the public event can become a tradable Yes/No question.
This item has a verifiable event angle that can be monitored for a Yes/No prediction market.